Mustang Bio Inc

-0.12 (-4.94%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)18.02M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$3 Million
Adjusted EPS-$1.11
See more estimates
10-Day MA$2.53
50-Day MA$3.75
200-Day MA$5.78
See more pivots

Mustang Bio Inc Stock, NASDAQ:MBIO

377 Plantation Street, 1st floor, Worcester, Massachusetts 01605-2245
United States of America
Phone: +1.781.652.4500
Number of Employees: 113


Mustang Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the translation of medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline includes CAR T therapies for hematologic malignancies, CAR T therapies for solid tumors, and gene therapies for rare genetic disorders. The company was founded on March 13, 2015 and is headquartered in Worcester, MA.